Loading...
Derniers dépôts
-
-
-
-
-
Francesco Galli, Laricia Bragg, Maira Rossi, Daisy Proietti, Laura Perani, et al.. Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy. EMBO Molecular Medicine, 2024, 16 (4), pp.927 - 944. ⟨10.1038/s44321-024-00031-3⟩. ⟨hal-04603972⟩
-
-
-
Julia Pereira Lemos, Liliane Patrícia Gonçalves Tenório, Vincent Mouly, Gillian Butler-Browne, Daniella Arêas Mendes-Da-Cruz, et al.. T cell biology in neuromuscular disorders: a focus on Duchenne Muscular Dystrophy and Amyotrophic Lateral Sclerosis. Frontiers in Immunology, 2023, 14, pp.120283. ⟨10.3389/fimmu.2023.1202834⟩. ⟨hal-04603915⟩
-
-
-
-
Angelos Gerassimopoulos, Céline Michaud, Mélanie Gaillet, Cyril Rousseau, Adriana Gonzalez, et al.. Santé et recours aux soins et à la prévention des travailleuses du sexe dominicaines vivant le long du fleuve Maroni. 6e journées des travaux scientifiques des soignant.e.s de Guyane, May 2023, Cayenne, Guyane française. ⟨hal-04585175⟩
-
Joe-Elie Salem, Marie Bretagne, Baptiste Abbar, Sarah Leonard-Louis, Stéphane Ederhy, et al.. Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis. Cancer Discovery, 2023, 13 (5), pp.1100-1115. ⟨10.1158/2159-8290.CD-22-1180⟩. ⟨hal-04578810⟩
-
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Vanessa Ueberschlag-Pitiot, Amalia Stantzou, Julien Messéant, Megane Lemaitre, Daniel Owens, et al.. Gonad-related factors promote muscle performance gain during postnatal development in male and female mice. AJP - Endocrinology and Metabolism, 2017, 313 (1), pp.E12-E25. ⟨10.1152/ajpendo.00446.2016⟩. ⟨hal-03677800⟩
-
-
-
Hubert Smeets, Bram Verbrugge, Xavier Bulbena, Liliya Hristova, Julia Vogt, et al.. European Joint Programme on Rare Diseases workshop: LAMA2-muscular dystrophy: paving the road to therapy March 17–19, 2023, Barcelona, Spain. LAMA2-muscular dystrophy: paving the road to therapy, Neuromuscular Disorders, 36, pp.16 - 22, 2024, ⟨10.1016/j.nmd.2024.01.001⟩. ⟨hal-04546346⟩
-
Nombre de documents
790
Nombre de notices
1 381
widget_cloud
Dynamin 2
Fabry disease
Satellite cells
Myasthenia Gravis MG
Laminopathies
Calcium
Therapy
Autophagy
Myotonic dystrophy
Congenital myopathy
Cytokines
Cell therapy
Myasthenia gravis
AAV
Male
Autoantibodies
Thymus
ALS
Astrocyte
Genotype phenotype correlation
Long read sequencing
Becker muscular dystrophy
Aging
Dystrophin
Alternative splicing
Satellite cell
Antisense oligonucleotides
Autoimmunity
Myopathies
Congenital muscular dystrophy
Myogenesis
Neuromuscular junction
Thérapie génique
RNA interference
RNA biology
DMD
Cardiomyopathy
Transcriptomics
Laminopathie
Inflammation
Myotonic Dystrophy
Aged
Mechanotransduction
Myotonic Dystrophy type 1
Muscular dystrophy
Clinical trials
Muscle
Skeletal muscle
OPMD
MBNL
Nuclear envelope
Mouse model
Muscle regeneration
CRISPRi
FSHD
Humans
Cancer
Oxidative stress
Animals
Amyotrophic lateral sclerosis
Motoneuron
Exercise
Gene therapy
Heart failure
Regeneration
Laminopathy
Dilated cardiomyopathy
Biomarker
Biomarkers
CMS
LMNA
Rare neuromuscular diseases
Heart
Fibrosis
Neuromuscular diseases
Lamin A/C
Lamin A/C LMNA gene
Dermatomyositis
Centronuclear myopathy
Brain
Actin
Cytoskeleton
Myotonic dystrophy type 1
COVID-19
Treatment
Outcome measures
Rare diseases
CTG repeat contractions
Duchenne muscular dystrophy
Trinucleotide repeat expansion
Myositis
Autoimmune diseases
Neuromuscular disease
Transgenic mouse model
Glutamate
Myopathy
LMNA gene
Errance diagnostique
Myoblasts
PABPN1